Fonar Corp financial data

Symbol
FONR on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
110 Marcus Dr, Melville, NY
State of incorporation
DE
Fiscal year end
June 30
Latest financial report
10-Q - Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 894 % +10.3%
Debt-to-equity 30.2 % -8.38%
Return On Equity 7.1 % +1.28%
Return On Assets 5.39 % +3.06%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 106M USD +11.8%
Weighted Average Number of Shares Outstanding, Basic 6.34M shares -2.25%
Weighted Average Number of Shares Outstanding, Diluted 6.61M shares -1.09%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 103M USD +5.16%
Research and Development Expense 1.74M USD +15.1%
Costs and Expenses 85M USD +4.69%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 20.3M USD +21.3%
Income Tax Expense (Benefit) 5.63M USD +80.8%
Net Income (Loss) Attributable to Parent 11M USD +5.7%
Earnings Per Share, Basic 1.48 USD/shares -4.52%
Earnings Per Share, Diluted 0.55 USD/shares +71.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 136M USD +11.3%
Property, Plant and Equipment, Net 19.3M USD -15.5%
Operating Lease, Right-of-Use Asset 37.8M USD +12.5%
Intangible Assets, Net (Excluding Goodwill) 3.18M USD -9.02%
Goodwill 4.27M USD 0%
Assets 210M USD +5.17%
Accounts Payable, Current 1.68M USD -2.5%
Liabilities, Current 14.5M USD +4.15%
Long-term Debt and Lease Obligation 115K USD -25.9%
Operating Lease, Liability, Noncurrent 36.5M USD +11.8%
Liabilities 52.6M USD +7.97%
Retained Earnings (Accumulated Deficit) -14.5M USD +43.2%
Stockholders' Equity Attributable to Parent 166M USD +5.46%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 157M USD +4.26%
Liabilities and Equity 210M USD +5.17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.62M USD -2.93%
Net Cash Provided by (Used in) Financing Activities -2.13M USD -20.7%
Net Cash Provided by (Used in) Investing Activities -79K USD +91.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 54M USD +8.75%
Interest Paid, Excluding Capitalized Interest, Operating Activities 48K USD +220%
Deferred Tax Assets, Valuation Allowance 364K USD -17.6%
Deferred Tax Assets, Gross 10.4M USD -21.7%
Operating Lease, Liability 37.4M USD +17.7%
Payments to Acquire Property, Plant, and Equipment 63K USD -93.3%
Property, Plant and Equipment, Gross 61.7M USD +6.25%
Operating Lease, Liability, Current 3.64M USD -8.69%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.35M USD +10.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.4M USD +10.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 1.24M USD +8.38%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.21M USD +9.06%
Deferred Tax Assets, Operating Loss Carryforwards 2.77M USD -42.6%
Deferred Federal Income Tax Expense (Benefit) 719K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.85M USD +3.57%
Additional Paid in Capital 181M USD -1.91%
Current Federal Tax Expense (Benefit) 1.13M USD
Depreciation, Depletion and Amortization 4.73M USD +8.74%
Deferred Tax Assets, Net of Valuation Allowance 7.04M USD -35.5%
Interest Expense 76.1K USD -40%